Rethinking Extended Adjuvant Antiestrogen Therapy for Breast Cancer
This Viewpoint discusses the potential for reducing recurrence and mortality in patients with high-risk estrogen receptor–positive breast cancer by using an affordable intermittent salvage therapy.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου